Skip to main content
. 2021 Sep 2;13(9):1391. doi: 10.3390/pharmaceutics13091391

Figure 9.

Figure 9

Tumor-specific CPP-conjugate delivery strategies. To additionally improve intracellular uptake of conjugates via CPPs, cargos can be conjugated to either tumor-homing CPPs (A), tumor-homing moiety (B) or a specific antibody for a membrane receptor (C). CPPs can enter any kind of cell, but the cargo is only active inside tumorous cells where molecular pathways are deregulated (D). CPP-based drugs can be activated in the proximity of the tumor microenvironment (E).